跳至主要内容
临床试验/ACTRN12610000711011
ACTRN12610000711011已完成未知

Trans Tasman Radiation Oncology Group (TROG) 10.01 - A multi-centre feasibility study of online adaptive image guided radiotherapy for muscle invasive bladder cancer

Trans Tasman Radiation Oncology Group (TROG)0 个研究点目标入组 50 人开始时间: 2010年8月26日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Aged 18 years or older 2. Has provided written Informed Consent for participation in this trial 3. Histologically confirmed muscle invasive bladder cancer. 4. Transitional cell, squamous cell, adenocarcinoma or mixed histology. Stage T2-4 N0 M0. 5. An Eastern Cooperative Oncology Group (ECOG) performance status score of 2 or less. 6. Life expectancy greater than 6 months. 7. Considered suitable for radical radiotherapy.
  • 8. Participants capable of childbearing are using adequate contraception. 9. Radiotherapy must be able to be commenced within 12 weeks of surgery. 10. Available for follow up.

排除标准

  • 1. Women who are pregnant or lactating. 2. Previous pelvic radiotherapy 3. Previous cystectomy 4. A small contracted bladder 5. Unilateral or bilateral hip replacement 6. Small cell histology 7.Clinical or radiological evidence of nodal or distant metastases 8. Presence of indwelling urinary catheter

研究者

发起方
Trans Tasman Radiation Oncology Group (TROG)

相似试验